Addus CEO sells 7,352 shares under 10b5-1 plan

Addus HomeCare Corp Chairman and CEO Dirk Allison reported selling a total of 7,352 shares of common stock in open-market transactions.

Rhea-AI Filing Summary

Addus HomeCare Corp Chairman and CEO Dirk Allison reported selling a total of 7,352 shares of common stock in open-market transactions. He sold 4,988 shares at an average price of $106.98 on February 24 and 2,364 shares at $105.36 on February 25. These sales were made under a previously established Rule 10b5-1 trading plan to cover tax obligations from vesting restricted stock awards. After the transactions, he directly owns 183,150 shares of Addus HomeCare common stock.

Insider Trade Summary

Net Seller: 7,352 shares

Net Sell 2 txns

Insider ALLISON R DIRK

Role Chairman and CEO

Sold 7,352 shs ($783K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,364	$105.36	$249K
Sale	Common Stock	4,988	$106.98	$534K

Holdings After Transaction: Common Stock — 183,150 shares (Direct)

Footnotes (2)

1. F1. This transaction reflects the sale of shares, made pursuant to a previously established 10b5-1 plan, for the purpose of satisfying tax obligations due upon the vesting of restricted stock awards granted by the Issuer.
2. F2. Adoption date of referenced 10b5-1(c) plan is: 03-04-2025

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Addus HomeCare (ADUS) report for Dirk Allison?

Dirk Allison reported selling 7,352 shares of Addus HomeCare common stock. The sales occurred in two open-market transactions on February 24 and 25 at prices around $106–$105 per share under a pre-arranged Rule 10b5-1 plan.

How many Addus HomeCare (ADUS) shares did the CEO sell and at what prices?

The CEO sold 4,988 shares at $106.98 per share on February 24 and 2,364 shares at $105.36 per share on February 25. In total, 7,352 shares of Addus HomeCare common stock were sold in these open-market transactions.

Why were Dirk Allison’s Addus HomeCare (ADUS) share sales executed under a 10b5-1 plan?

The sales were executed under a previously established Rule 10b5-1 plan to satisfy tax obligations. Those obligations arose from the vesting of restricted stock awards granted by Addus HomeCare, helping automate the sales independently of short-term market conditions or personal discretion.

When was the 10b5-1 trading plan for Addus HomeCare (ADUS) CEO Dirk Allison adopted?

The 10b5-1(c) trading plan referenced for these sales was adopted on March 4, 2025. This pre-arranged plan governed the automatic sale of shares to address tax liabilities tied to vesting restricted stock awards granted by Addus HomeCare.

How many Addus HomeCare (ADUS) shares does CEO Dirk Allison own after these sales?

Following the reported transactions, Dirk Allison directly owns 183,150 shares of Addus HomeCare common stock. This figure reflects his holdings after selling a combined 7,352 shares in two open-market transactions executed pursuant to a previously established Rule 10b5-1 plan.

Were the recent Addus HomeCare (ADUS) CEO share sales open-market transactions?

Yes, both transactions were open-market sales of Addus HomeCare common stock. The Form 4 describes them as sales in the open market or private transactions, executed under a Rule 10b5-1 plan designed to cover tax obligations from restricted stock vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/26/2026 - 04:30 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ALLISON R DIRK

(Last) (First) (Middle)

6303 COWBOYS WAY

SUITE 600

(Street)

FRISCO TX 75034

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman and CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/24/2026		S(1)(2)		4,988	D	$106.98	185,514	D
Common Stock	02/25/2026		S(1)(2)		2,364	D	$105.36	183,150	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction reflects the sale of shares, made pursuant to a previously established 10b5-1 plan, for the purpose of satisfying tax obligations due upon the vesting of restricted stock awards granted by the Issuer.

2. Adoption date of referenced 10b5-1(c) plan is: 03-04-2025

	/s/ Brian Poff, Attorney-in-Fact for R. Dirk Allison	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.